Alector, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0144421072
USD
1.21
0.07 (6.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1249006,
    "name": "Alector, Inc.",
    "stock_name": "Alector, Inc.",
    "full_name": "Alector, Inc.",
    "name_url": "stocks-analysis/alector-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.21",
    "chg": 0.07,
    "chgp": "6.14%",
    "dir": 1,
    "prev_price": "1.14",
    "mcapval": "279.35",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US0144421072",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.58 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alector-inc-1249006-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Alector, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alector-inc-technically-bullish-or-bearish-3547383",
        "imagepath": "",
        "date": "2025-09-20 19:54:06",
        "description": "As of 11 September 2025, the technical trend for Alector, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a mildly bearish signal on the monthly timeframe. The KST is bullish on the weekly but bearish on the monthly, while the Dow Theory indicates a mildly bullish stance for both weekly and monthly periods. \n\nIn terms of performance, Alector has outperformed the S&P 500 over the past week and month, with returns of 9.06% and 46.95%, respectively, compared to 1.05% and 2.33% for the index. However, the longer-term returns are significantly negative, with a 1-year return of -44.50% and a 3-year return of -66.09%. Overall, the current technical stance is bullish, but the strength appears mixed due to the divergence in some indicators and the p..."
      },
      {
        "title": "Is Alector, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alector-inc-overvalued-or-undervalued-3543772",
        "imagepath": "",
        "date": "2025-09-20 18:28:15",
        "description": "As of 8 November 2022, Alector, Inc. moved from fair to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 1.57 and an EV to EBIT of 1.30, which suggest that investors are paying a premium relative to the company's underlying assets and earnings potential. Additionally, the ROCE stands at a high 59.50%, but this is overshadowed by a troubling ROE of -128.14%, reflecting significant losses.\n\nIn comparison to its peers, Alector's valuation ratios are concerning; for instance, Avid Bioservices, Inc. has a P/E ratio of -5.2542 while Editas Medicine, Inc. shows a P/E of -1.5909, both indicating a similar risk profile. The overall peer comparison highlights that Alector is not only risky but also underperforming relative to its industry counterparts. Although return data is not available, the lack..."
      }
    ],
    "total": 7,
    "sid": "1249006",
    "stock_news_url": "https://www.marketsmojo.com/news/alector-inc-1249006"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available